Health & biology · around 2032

Routine in-body gene editing

Projection

A single infusion edits genes inside the body, curing inherited and common diseases.

Lipid nanoparticles deliver base or prime editors to the liver and other organs. One-time treatments for conditions like high cholesterol or genetic disorders would replace lifelong drugs.

Why it’s plausible: The first CRISPR therapy was approved in 2023 and in-body editing has worked in trials; wide use depends on delivery beyond the liver, long-term safety data and cost.

See it in the living treeWikipedia